Interleukin-7-loaded oncolytic adenovirus improves CAR-T cell therapy for glioblastoma

溶瘤腺病毒 溶瘤病毒 体内 癌症研究 T细胞 医学 离体 细胞疗法 免疫学 细胞 免疫系统 生物 免疫疗法 嵌合抗原受体 遗传学 生物技术
作者
Jianhan Huang,Meijun Zheng,Zongliang Zhang,Xin Tang,Yaxing Chen,Aijun Peng,Xingchen Peng,Aiping Tong,Liangxue Zhou
出处
期刊:Cancer Immunology, Immunotherapy [Springer Science+Business Media]
卷期号:70 (9): 2453-2465 被引量:96
标识
DOI:10.1007/s00262-021-02856-0
摘要

T cell with chimeric antigen receptors (CAR-T) has presented remarkable efficacy for blood cancer as an emerging immunotherapy. However, for solid tumors, the therapeutic efficacy is much impaired due to the lack of infiltration and persistence of CAR-T in tumor tissue. Thus, we constructed an interleukin-7-loaded oncolytic adenovirus and combined the use of oncolytic virus and CAR-T to improve the therapeutic outcome. We constructed an interleukin-7-loaded oncolytic adenovirus (oAD-IL7) and a B7H3-targeted CAR-T and explored the efficacy of the single use of oAD-IL7, B7H3-CAR-T, or the combined therapy for glioblastoma in vitro and in vivo. The improved CAR-T anti-tumor efficacy was evaluated according to the proliferation, survival, persistence, exhaustion of T cells, and tumor regression. Constructed oAD-IL7 and B7H3-CAR-T presented moderate cytotoxicity during in vitro study, but failed to induce a thorough and persistent anti-tumor therapeutic efficacy in vivo. The combination of oAD-IL7 and B7H3-CAR-T in vitro resulted in enhanced T cell proliferation and reduced T cell apoptosis. The joint efficacy was further confirmed using tumor-bearing xenograft mice. During in vivo study, the mice treated with both oAD-IL7 and B7H3-CAR-T showed prolonged survival and reduced tumor burden. According to the ex vivo study, oAD-IL7 improved the proliferation and persistence of tumor-infiltrating B7H3-CAR-T, but failed to reverse the exhaustion. Our results indicated that oAD-IL7 is a promising auxiliary therapy to improve the therapeutic efficacy of B7H3-CAR-T in glioblastoma by providing the activating signals for tumor-infiltrating T cells. Our results also lay the basis for the future clinical trials for the combination of IL7-loaded oncolytic adenovirus and CAR-T therapy for glioblastoma.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zd200572完成签到,获得积分10
1秒前
秋风的应助被深情的猫咪采纳,获得10
1秒前
1秒前
1秒前
酷波er的应助被想人陪的蚂蚁采纳,获得10
1秒前
李健的小迷弟的应助被1282941496采纳,获得10
1秒前
1秒前
3秒前
3秒前
Ava的应助被无限觅风采纳,获得10
3秒前
4秒前
yu123发布了新的文献求助10
4秒前
忧伤的老四完成签到,获得积分10
4秒前
5秒前
DJC完成签到,获得积分10
6秒前
6秒前
11发布了新的文献求助10
6秒前
烟花的应助被许自通采纳,获得10
7秒前
7秒前
7秒前
暖暖发布了新的文献求助10
7秒前
8秒前
thomas发布了新的文献求助10
8秒前
9秒前
山海不远发布了新的文献求助10
9秒前
chiaugustus完成签到,获得积分10
9秒前
12秒前
梦梦的应助被东十八采纳,获得10
12秒前
12秒前
桃桃奶盖发布了新的文献求助10
12秒前
abydauw发布了新的文献求助10
13秒前
白塔发布了新的文献求助20
13秒前
13秒前
传奇3的应助被泊宁采纳,获得10
14秒前
14秒前
情怀的应助被邦邦的幸福生活采纳,获得10
14秒前
小陈完成签到,获得积分20
14秒前
Hello的应助被坦率起眸采纳,获得10
14秒前
马大顶完成签到,获得积分10
15秒前
EASA发布了新的文献求助10
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175336
求助须知:如何正确求助?哪些是违规求助? 9567158
关于积分的说明 21790491
捐赠科研通 7769866
什么是DOI,文献DOI怎么找? 3431849
关于科研通互助平台的介绍 2556178
邀请新用户注册赠送积分活动 2477280